IT8522058A0 - Perfezionamenti riguardanti la terapia con ciclosporine. - Google Patents

Perfezionamenti riguardanti la terapia con ciclosporine.

Info

Publication number
IT8522058A0
IT8522058A0 IT8522058A IT2205885A IT8522058A0 IT 8522058 A0 IT8522058 A0 IT 8522058A0 IT 8522058 A IT8522058 A IT 8522058A IT 2205885 A IT2205885 A IT 2205885A IT 8522058 A0 IT8522058 A0 IT 8522058A0
Authority
IT
Italy
Prior art keywords
improvements regarding
cyclosporine therapy
cyclosporine
therapy
regarding
Prior art date
Application number
IT8522058A
Other languages
English (en)
Other versions
IT1209659B (it
Inventor
Helene Siegl
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IT8522058A0 publication Critical patent/IT8522058A0/it
Application granted granted Critical
Publication of IT1209659B publication Critical patent/IT1209659B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
IT8522058A 1984-09-04 1985-09-03 Perfezionamenti riguardanti la terapia con ciclosporine. IT1209659B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848422253A GB8422253D0 (en) 1984-09-04 1984-09-04 Organic compounds

Publications (2)

Publication Number Publication Date
IT8522058A0 true IT8522058A0 (it) 1985-09-03
IT1209659B IT1209659B (it) 1989-08-30

Family

ID=10566202

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8522058A IT1209659B (it) 1984-09-04 1985-09-03 Perfezionamenti riguardanti la terapia con ciclosporine.

Country Status (9)

Country Link
US (1) US4681754A (it)
EP (1) EP0174279A3 (it)
JP (1) JPS6183124A (it)
AU (1) AU580797B2 (it)
DK (1) DK400485A (it)
GB (1) GB8422253D0 (it)
IT (1) IT1209659B (it)
PH (1) PH22200A (it)
ZA (1) ZA856794B (it)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8602372D0 (en) * 1986-01-31 1986-03-05 Sandoz Ltd Organic compounds
DE3888357T2 (de) * 1987-06-22 1994-09-15 Merck & Co Inc Cyclosporin-Derivate, die eine modifizierte Aminosäure auf Stellung 8 tragen.
EP0300675A3 (en) * 1987-07-21 1990-04-11 Merck Frosst Canada Inc. Method for the improvement of cyclosporine therapy
US5227467A (en) * 1987-08-03 1993-07-13 Merck & Co., Inc. Immunosuppressive fluorinated cyclosporin analogs
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin
WO1989001772A1 (en) * 1987-09-03 1989-03-09 University Of Georgia Research Foundation, Inc. Ocular cyclosporin composition
US4914188A (en) * 1987-11-16 1990-04-03 Merck & Co., Inc. Novel 6-position cyclosporin analogs as non-immunosuppressive antagonists of cyclosporin binding to cyclophilin
US5236899A (en) * 1987-11-16 1993-08-17 Merck & Co., Inc. 6-position cyclosporin a analogs as modifiers of cytotoxic drug resistance
AU4958590A (en) * 1988-12-05 1990-07-10 Trustees Of Columbia University In The City Of New York, The Novel derivatives of cyclosporine a, antibodies directed thereto and uses thereof
US5604092A (en) 1988-12-05 1997-02-18 The Trustees Of Columbia University In The City Of New York Method for the detection of HIV-1 using a cyclosporine-specific monoclonal antibody that reacts with the P24 Gag protein
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
US5122511A (en) * 1990-02-27 1992-06-16 Merck & Co., Inc. Immunosuppressive cyclosporin analogs with modified amino acids at position-8
US20030220234A1 (en) * 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
ATE423130T1 (de) 1997-10-08 2009-03-15 Isotechnika Inc Deuterierte cyclosporin-analoga und ihre verwendung als immunmodulierende agenzien
US6713081B2 (en) * 2001-03-15 2004-03-30 The United States Of America As Represented By The Department Of Health And Human Services Ocular therapeutic agent delivery devices and methods for making and using such devices
DK1436321T3 (da) * 2001-10-19 2006-11-13 Isotechnika Inc Syntese af cyclosporinanaloger

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH614931A5 (it) * 1975-11-04 1979-12-28 Sandoz Ag
DE2819094A1 (de) * 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung
SE448386B (sv) * 1978-10-18 1987-02-16 Sandoz Ag Nya cyklosporinderivat, forfarande for framstellning av dem samt farmaceutisk komposition innehallande dem

Also Published As

Publication number Publication date
DK400485A (da) 1986-03-05
EP0174279A2 (en) 1986-03-12
ZA856794B (en) 1987-04-29
JPS6183124A (ja) 1986-04-26
US4681754A (en) 1987-07-21
AU4695085A (en) 1986-03-13
DK400485D0 (da) 1985-09-02
EP0174279A3 (en) 1989-01-25
GB8422253D0 (en) 1984-10-10
AU580797B2 (en) 1989-02-02
PH22200A (en) 1988-06-28
IT1209659B (it) 1989-08-30

Similar Documents

Publication Publication Date Title
NO854540L (no) Tynnplatekonstruksjon.
IT8521079A0 (it) Rivestimento microlaminato.
ATE41922T1 (de) Alkylsulfonamidophenylalkylamine.
FI862128A0 (fi) Individuell parkeringsmaetare.
IT8522058A0 (it) Perfezionamenti riguardanti la terapia con ciclosporine.
FI850946L (fi) Medicinska plaoster.
DE3581730D1 (de) Menschlicher tumornekrosisfaktor.
DE3578058D1 (de) Schiffsbodenstruktur.
FI853249A0 (fi) Cdna-kloner foer human erytropoietin.
FI850193L (fi) Terapeutiska lhrh analoger.
FI862904A0 (fi) Dubbelviraformare.
DE3586406D1 (de) Tabelliersystem.
FI851488L (fi) Peptider.
FI860739A (fi) Undervattensopererande system.
FI843846L (fi) System foer luftfuktning.
ATE89289T1 (de) Cyclosporine.
ES283400Y (es) Interruptor-conmutador mejorado.
ATE66932T1 (de) Gnrh-antagonisten-vii.
FI843761A0 (fi) Anordning foer rengoering av blod.
FI843762A0 (fi) Anordning foer rengoering av blod.
IT8430748V0 (it) Porzione savoiardi.
ATE47325T1 (de) Spielbausteinsystem.
IT8444203A0 (it) W.c.b. system
IT8433307V0 (it) W.c.b. system
NO156382C (no) Forskalingssystem.